MarketPeel
Insider Trading Intelligence
Pricing
…
MC

Meredith Cook

ANIP
SR. VP, GENERAL COUNSEL & SEC. · ANI PHARMACEUTICALS INC · CIK 0001938861
FILING MIX · LIFETIME16%/84%
BUYS
8
SELLS
43
TOTAL VALUE
$3.08M
COMPANIES
1
ACTIVE SINCE
Jul 2022
HOLDINGS NOW
77,390
AVG SELL PX
$69.26
TRADE KIND
SHOWING 51 / 51
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
31 backtested trades · 8 horizons · 37 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Meredith Cook, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d31+41.94%+0.59%+0.29%+0.39%+0.83%0.49
14d31+48.39%+1.18%+1.14%+0.05%-0.66%0.06
30d31+38.71%+2.27%+1.96%+0.31%-1.28%0.18
60d31+45.16%+4.38%+3.55%+0.84%-2.28%0.33
90d31(1 pending)+46.67%+5.94%+5.24%+0.70%-5.65%0.22
180d31(4 pending)+37.04%+10.03%+9.40%+0.62%-0.15%—
1y31(10 pending)+19.05%+22.88%+19.03%+3.85%-4.00%—
2y31(22 pending)+0.00%+35.79%+42.30%-6.50%-5.57%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ANIP · 77,390 shares · as of Jul 13, 2026
020,97041,93962,90983,8782023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 8 buys / 43 sellsCOVERAGE · 17 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
500$81.84$40.9K77,390Jul 13, 2026Jul 14, 2026 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
500$82.03$41.0K77,890Jun 12, 2026Jun 15, 2026 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
500$78.16$39.1K78,390May 13, 2026May 13, 2026 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
500$77.95$39.0K78,890Apr 13, 2026Apr 13, 2026 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
500$72.62$36.3K79,390Mar 13, 2026Mar 13, 2026 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SR. VP, GENERAL COUNSEL & SEC.
1,555$73.90$114.9K79,890Feb 28, 2026Mar 2, 2026 ↗View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
13,895$77.15$1.07M81,445Feb 26, 2026Mar 2, 2026 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SR. VP, GENERAL COUNSEL & SEC.
1,779$77.36$137.6K67,550Feb 14, 2026Feb 17, 2026 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
500$76.80$38.4K69,329Feb 13, 2026Feb 17, 2026 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SR. VP, GENERAL COUNSEL & SEC.
1,534$76.70$117.7K69,829Feb 12, 2026Feb 17, 2026 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SR. VP, GENERAL COUNSEL & SEC.
3,011$76.25$229.6K71,363Feb 11, 2026Feb 13, 2026 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
500$84.33$42.2K74,374Jan 13, 2026Jan 14, 2026 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
400$82.32$32.9K74,874Dec 12, 2025Dec 12, 2025 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
400$87.27$34.9K75,274Nov 13, 2025Nov 14, 2025 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
400$90.09$36.0K75,674Oct 13, 2025Oct 14, 2025 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
400$98.42$39.4K76,074Sep 12, 2025Sep 15, 2025 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
400$88.87$35.5K76,474Aug 13, 2025Aug 14, 2025 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SR. VP, GENERAL COUNSEL & SEC.
2,071$66.30$137.3K76,874Jul 18, 2025Jul 21, 2025 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
400$64.88$26.0K78,945Jul 14, 2025Jul 14, 2025 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
400$61.37$24.5K79,345Jun 13, 2025Jun 16, 2025 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
400$62.20$24.9K79,745May 13, 2025May 13, 2025 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
400$68.96$27.6K80,145Apr 14, 2025Apr 14, 2025 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
400$63.33$25.3K80,545Mar 13, 2025Mar 14, 2025 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SR. VP, GENERAL COUNSEL & SEC.
1,099$61.89$68.0K80,945Feb 28, 2025Mar 4, 2025 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SR. VP, GENERAL COUNSEL & SEC.
1,434$58.92$84.5K82,044Feb 14, 2025Feb 18, 2025 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
400$59.54$23.8K83,478Feb 13, 2025Feb 18, 2025 ↗View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
16,974——72,562Feb 12, 2025Feb 18, 2025 ↗View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
11,316——83,878Feb 12, 2025Feb 18, 2025 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
400$53.92$21.6K55,588Jan 13, 2025Jan 13, 2025 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
250$56.24$14.1K55,988Dec 13, 2024Dec 16, 2024 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
250$61.36$15.3K56,238Nov 13, 2024Nov 14, 2024 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
250$57.19$14.3K56,488Oct 14, 2024Oct 15, 2024 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
250$56.82$14.2K56,738Sep 13, 2024Sep 16, 2024 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
250$59.62$14.9K56,988Aug 13, 2024Aug 14, 2024 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SR. VP, GENERAL COUNSEL & SEC.
1,743$61.35$106.9K57,238Jul 18, 2024Jul 18, 2024 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
250$64.91$16.2K58,981Jul 12, 2024Jul 15, 2024 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
250$63.80$15.9K59,231Jun 13, 2024Jun 14, 2024 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
250$67.69$16.9K59,481May 13, 2024May 13, 2024 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
250$67.79$16.9K59,731Apr 12, 2024Apr 15, 2024 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
250$66.54$16.6K59,981Mar 13, 2024Mar 13, 2024 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SR. VP, GENERAL COUNSEL & SEC.
1,173$67.67$79.4K60,231Feb 29, 2024Mar 1, 2024 ↗View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
9,842——61,404Feb 14, 2024Feb 16, 2024 ↗View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
14,763——51,562Feb 14, 2024Feb 16, 2024 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
250$56.04$14.0K36,799Feb 13, 2024Feb 13, 2024 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
250$56.43$14.1K37,049Jan 12, 2024Jan 16, 2024 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
250$49.21$12.3K37,299Dec 11, 2023Dec 11, 2023 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
250$52.03$13.0K37,549Nov 13, 2023Nov 14, 2023 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SR. VP, GENERAL COUNSEL & SEC.
1,743$51.89$90.4K37,799Jul 18, 2023Jul 19, 2023 ↗View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
12,158——31,438Feb 28, 2023Apr 4, 2023 ↗View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
8,104——39,542Feb 28, 2023Apr 4, 2023 ↗View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
19,280——19,280Jul 18, 2022Jul 20, 2022 ↗View →
Other insiders · ANIP
Loading peer insiders…
About this filer
CIK 0001938861
ROLE
SR. VP, GENERAL COUNSEL & SEC.
PRIMARY
ANIP
COMPANIES
1
ACTIVE SINCE
Jul 2022
MARKETPEEL · /INSIDER/0001938861DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback